Kamil Jackson | Chief Legal Officer |
Neal Walker | President and CEO |
Chris Powala | Chief Regulatory Officer and Chief Development Officer |
Stuart Shanler | Chief Scientific Officer |
Frank Ruffo | CFO |
Brett Fair | Chief Commercial Officer |
Louise Chen | Cantor Fitzgerald |
Adnan Butt | Guggenheim Securities |
Donald Ellis | JMP Securities |
Tim Lugo | William Blair |
Seamus Fernandez | Leerink Partners |
Liav Abraham | Citi |
Good day, ladies and gentlemen, and welcome to the Q4 2017 Aclaris Therapeutics Inc. Earnings Conference Call. At this time, all participants are in a listen-only-mode. Later, we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions].